Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury
- PMID: 28104771
- DOI: 10.1161/CIRCRESAHA.116.308434
Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury
Abstract
The discovery of thousands of noncoding RNAs (ncRNAs) has expanded our view on mammalian genomes and transcriptomes, as well as their organization and regulation. Accumulating evidence on aberrantly regulated ncRNAs, including short microRNAs, long ncRNAs and circular RNAs, across various heart diseases indicates that ncRNAs are critical contributors to cardiovascular pathophysiology. In addition, ncRNAs are released into the circulation where they are present in concentration levels that differ between healthy subjects and diseased patients. Although little is known about the origin and function of such circulating ncRNAs, these molecules are increasingly recognized as noninvasive and readily accessible biomarker for risk stratification, diagnosis and prognosis of cardiac injury, and multiple forms of cardiovascular disease. In this review, we summarize recent findings on biological characteristics of circulating ncRNAs and highlight their value as potential biomarker in selected pathologies of cardiovascular disease.
Keywords: RNA, long noncoding; RNA, untranslated; biomarkers; cardiovascular diseases; heart diseases.
© 2017 American Heart Association, Inc.
Similar articles
-
Circulating Non-coding RNAs and Cardiovascular Diseases.Adv Exp Med Biol. 2020;1229:357-367. doi: 10.1007/978-981-15-1671-9_22. Adv Exp Med Biol. 2020. PMID: 32285424 Review.
-
The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.Acta Pharmacol Sin. 2018 Jul;39(7):1085-1099. doi: 10.1038/aps.2018.35. Epub 2018 Jun 7. Acta Pharmacol Sin. 2018. PMID: 29877319 Free PMC article. Review.
-
Noncoding RNAs as circulating biomarkers in osteosarcoma patients.J Cell Physiol. 2019 Nov;234(11):19249-19255. doi: 10.1002/jcp.28744. Epub 2019 Apr 29. J Cell Physiol. 2019. PMID: 31032924 Review.
-
Circulating MicroRNA and Long Noncoding RNA as Biomarkers of Cardiovascular Diseases.J Cell Physiol. 2016 Apr;231(4):751-5. doi: 10.1002/jcp.25174. Epub 2015 Sep 9. J Cell Physiol. 2016. PMID: 26308238 Review.
-
RNA (Epi)genetics in cardiovascular diseases.J Mol Cell Cardiol. 2015 Dec;89(Pt A):11-6. doi: 10.1016/j.yjmcc.2015.07.012. Epub 2015 Jul 20. J Mol Cell Cardiol. 2015. PMID: 26205296 Review.
Cited by
-
Alterations of long noncoding RNAs and mRNAs in extracellular vesicles derived from the murine heart post-ischemia-reperfusion injury.J Cell Mol Med. 2022 Dec;26(24):6006-6018. doi: 10.1111/jcmm.17617. Epub 2022 Nov 28. J Cell Mol Med. 2022. PMID: 36444487 Free PMC article.
-
Integrated bioinformatics and validation to construct lncRNA-miRNA-mRNA ceRNA network in status epilepticus.Heliyon. 2023 Nov 10;9(11):e22205. doi: 10.1016/j.heliyon.2023.e22205. eCollection 2023 Nov. Heliyon. 2023. PMID: 38074882 Free PMC article.
-
Endotyping in Heart Failure - Identifying Mechanistically Meaningful Subtypes of Disease.Circ J. 2021 Aug 25;85(9):1407-1415. doi: 10.1253/circj.CJ-21-0349. Epub 2021 Jun 8. Circ J. 2021. PMID: 34108305 Free PMC article. Review.
-
Non-Coding RNAs Regulate Spontaneous Abortion: A Global Network and System Perspective.Int J Mol Sci. 2022 Apr 11;23(8):4214. doi: 10.3390/ijms23084214. Int J Mol Sci. 2022. PMID: 35457031 Free PMC article. Review.
-
H19 Increases IL-17A/IL-23 Releases via Regulating VDR by Interacting with miR675-5p/miR22-5p in Ankylosing Spondylitis.Mol Ther Nucleic Acids. 2020 Mar 6;19:393-404. doi: 10.1016/j.omtn.2019.11.025. Epub 2019 Nov 29. Mol Ther Nucleic Acids. 2020. PMID: 31887550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
